Ribavirin aerosol for acute bronchiolitis

Clicks: 516
ID: 112215
1986
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #3 of 37 articles by views in archives of disease in childhood

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
A randomised double blind placebo controlled trial of treatment with an aerosolised antiviral agent, ribavirin, was conducted in 26 infants with clinically diagnosed bronchiolitis. Nebulised ribavirin (14 infants) or normal saline aerosol (12 infants) was given for 18 hours a day for at least three …
Reference Key
w1986archivesribavirin Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Barry W;Cockburn F;Cornall R;Price JF;Sutherland G;Vardag A;;
Journal archives of disease in childhood
Year 1986
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/3524473
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE clinical trials as topic humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't female male Infant newborn Clinical Trial Randomized Controlled Trial Double-Blind Method Random Allocation acute disease bronchiolitis aerosols viral / drug therapy* ribavirin / administration & dosage ribavirin / therapeutic use* respiratory syncytial viruses pmid:3524473 pmc1777824 doi:10.1136/adc.61.6.593 w barry f cockburn a vardag respirovirus infections / drug therapy* ribonucleosides / therapeutic use*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.